2-Hydroxyesterone: The 'good' estrogen

Journal of Endocrinology

Volumn 150, Issue SUPPL., 1996, Pages

  Bradlow, H L ^a   Telang, N T ^a   Sepkovic, D W ^a   Osborne, M P ^a  

^a Strang Cancer Research Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRONE; 2-HYDROXYESTRONE; ANTINEOPLASTIC AGENT; CATECHOL ESTROGEN; ESTRONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CONFERENCE PAPER; ESTROGEN ACTIVITY; GROWTH INHIBITION; HUMAN; PRIORITY JOURNAL; TUMOR GROWTH; BREAST TUMOR; FEMALE; HYDROXYLATION; METABOLISM; REVIEW;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; ESTROGENS, CATECHOL; FEMALE; HUMANS; HYDROXYESTRONES; HYDROXYLATION;

EID: 0029856102     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT & Hamalainen E 1995 Estrogen metabolism and excretion in oriental and caucasian women. Journal of the National Cancer Institute 87 147-149.
2. Anderson KE, Kappas A, Conney AH, Bradlow HL & Fishman J 1984 The influence of dietary protein and carbohydrate on the principal oxidative biotransformations of estradiol in normal subjects. Journal of Clinical Endocrinology and Metabolism 59 103-107.
3. Bradlow HL, Hershcopf RJ, Martucci CP & Fishman J 1985 Estradiol 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans Proceedings of the National Academy of Sciences of the USA 82 6295-6299.
4. Bradlow HL, Michnovicz JJ, Wong GYC, Halper MP, Miller D & Osborne MP 1995a Long term responses of women to indole-3-carbinol or a high fiber diet. Cancer Prevention, Biomarkers and Epidemiology 3 591-595.
5. Bradlow HL, Sepkovic DW, Telang NT & Osborne MP 1995b Indole-3-carbinol: A novel approach to breast cancer prevention. In Cancer Prevention. Ed HL Bradlow, MP Osborne & U Veronesi. Annals of the New York Academy of Sciences 768 180-200.
6. Clark JH, Paszko Z & Peck EJ Jr 1977 Nuclear binding and retention of the receptor estrogen complex Relation to the agonistic and antagonistic properties of estriol. Endocrinology 100 91-96.
7. Crane MM, Sepkovic DW, Robertson NK, Lopez A, Blackhurst DW, Sticca RP, Coker AL & Bradlow HL 1996 Association of estrogen urinary metabolites and breast cancer: Pilot study. Cancer Prevention, Biomarkers and Epidemiology (In Press).
8. Fishman J 1983 Aromatic hydroxylation of estradiol. Annual Reviews in Physiology 45 61-72.
9. Fishman J, Bradlow HL, Schneider J, Anderson KE & Kappas A 1980 Radiometric analysis of biological oxidations in man: sex differences in estradiol metabolism. Proceedings of the National Academy of Sciences of the USA 77 4957-4960.
10. Goldin BR & Gorbach SL 1988 Effect of diet on the plasma levels, metabolism, and excretion of estrogens. American Journal of Clinical Nutrition 48 787-790.
11. Gordon J, Cantrall WP, Albers HJ, Mauer S & Stolar SM 1964 Steroids and lipid metabolism. The hypocholesteremic effect of estrogen metabolites. Steroids 4 267-291.
12. Hsieh C, Pavia M, Lambe M, Lan SJ, Colditz GA, Ekbom A, Adami HO, Tricholoulos D & Willett WC 1994 Dual effect of parity on breast cancer risk. European Journal of Cancer 30A 969-973
13. Klug TL, Bradlow HL & Sepkovic DW 1994 Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16α-hydroxyestrone in urine. Steroids 59 648-654.
14. Lemon HM 1977 Clinical and experimental aspects of the anti-mammary carcinogenic activity of estriol. Frontiers of Hormone Research 5 155-174.
15. Lemon HM, Heidel JW & Rodriguez-Sierra JF 1991 A method for estimating catechol estrogen metabolism from excretion of non-catechol estrogens. Cancer 68 444-450.
16. Lemon HM, Heidel JW & Rodriguez Sierra JF 1992 Increased catechol estrogen metabolism as a risk factor for non-familial breast cancer. Cancer 69 457-465.
17. Li JJ, Li SA, Oberley TG & Parsons JA 1995 Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney. Relation to hormonal activity and cell proliferation. Cancer Research 55 4347-4351.
18. Li SA, Klicka J & Li JJ 1985 Estrogen 2- and 4-hydroxylase activity, catechol estrogen formation, and implications for estrogen carcinogenesis in the hamster kidney. Cancer Research 45 191-195.
19. Liehr J 1996 Hormone associated cancer: mechanistic similarities between human breast cancer and estrogen induced kidney carcinogenesis in hamsters. Environmental Health Perspectives (In Press).
20. Liehr JG & Ulubelen A 1994 Microsome-mediated redox cycling of estrogens. Proceedings of the American Association for Cancer Research 16 6S.
21. Lustig RH, Kendrick-Parker CJ & Jordan VC 1994 Effects of 16α-hydroxyestrone on MCF-7 cell proliferation and estrogen receptor regulation in vitro Endocrine Society Proceedings 75 317.
22. Michnovicz JJ & Galbraith RA 1991 Cimetidine inhibits catechol estrogen metabolism in women. Metabolism 40 170-174.
23. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL & Fishman J 1986 Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New England Journal of Medicine 315 1305-1309
24. Miller CP, Jirkovsky I, Hayhurst DA & Adelman SJ 1996 Antioxidant effects of estrogens with a hindered 3-OH function on the copper induced oxidation of low density lipoprotein. Steroids 61 305-308.
25. Niwa T, Swaneck G & Bradlow HL 1994 Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds. Steroids 59 523-527
26. Osborne MP, Karmali RA, Hershcopf RJ, Bradlow HL, Kourides IA, Williams WR, Rosen PP & Fishman J 1988 Omega-3 fatty acids: Modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Investigations 8 629-631.
27. Ruiz-Larrea MB, Leal AM, Liza M, Lacort M & De Groot H 1994 Antioxidant effects of estradiol and 2-hydroxyestradiol on iron induced lipid peroxidation of rat liver microsomes. Steroids 59 383-388.
28. Schneider J, Bradlow HL, Strain G, Levin J, Anderson K & Fishman J 1983 Effects of obesity on estradiol metabolism, decreased formation of non-urerotropic metabolites. Journal of Clinical Endocrinology and Metabolism 56 973-978.
29. SchneiderJ, Huh MM, Bradlow HL & Fishman J 1984 Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. Journal of Biological Chemistry 259 4840-4845.
30. Schutze N, Vollmer G, Tiemann I, Geiger M & Knuppen R 1993 Catechol estrogens are MCF-7 estrogen receptor agonists Journal of Steroid Biochemistry and Molecular Biology 46 781-789.
31. Schutze N, Vollmer G, Wunsche W, Grote A, Feit B & Knuppen R 1994 Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to the estrogen receptor of MCF-7 cells in cytosolic extracts and in nuclei of intact cells. Experimental and Clinical Endocrinology 102 399-408.
32. Suto A, Bradlow HL, Wong GY, Osborne MP & Telang NT 1992 Persistent estrogen responsiveness of Ras oncogene-transformed mouse mammary epithelial cells. Steroids 57 262-268.
33. Suto A, Bradlow HL, Wong GY, Osborne MP & Telang NT 1993 Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Research and Treatment 27 193-202.
34. Taioli E, Trachtman J, Chem X, Sepkovic DW, Bradlow HL & Toniolo P 1996 Correlation of estradiol 2-hydroxylation and breast cancer risk in patients carrying the MSP-1 polymorphism of CyP4501A1. Proceedings of the American Association for Cancer Research Abstract No. 1697, p 249.
35. Telang NT, Kurihara H, Wong GY, Bradlow HL & Osborne MP 1991 Preneoplastic transformation in mouse mammary tissue: Identification and validation of intermediate biomarkers for chemoprevention Anticancer Research 11 1021-1027.
36. Telang NT, Suto A, Wong GY, Osborne MP & Bradlow HL 1992 Estrogen metabolite 16α-hydroxyestrone induces genotoxic damage and aberrant cell proliferation in mouse mammary epithelial cells in culture. Journal of the National Cancer Institute 84 634-638.
37. Ziegler RG, Rossi SC, Fears TR, Bradlow HL, Adlercreutz H, Sepkovic DW, Kiriu P, Wahala K, Vaught JB, Donaldson JL, Gail MH, Siiten PK & Hoover RN 1996 Quantifying estrogen metabolism: establishing the reproducibility and validity of assays for 2-hydroxyestrone and 16α-hydroxyestrone in urine. Environmental Health Perspectives (In Press).